Aster DM Healthcare Limited
Aster DM Healthcare Limited Fundamental Analysis
Aster DM Healthcare Limited (ASTERDM.BO) shows weak financial fundamentals with a PE ratio of 101.56, profit margin of 7.33%, and ROE of 8.60%. The company generates $44.6B in annual revenue with strong year-over-year growth of 11.88%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ASTERDM.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakASTERDM.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateASTERDM.BO shows balanced valuation metrics.
Growth Score
ModerateASTERDM.BO shows steady but slowing expansion.
Financial Health Score
ExcellentASTERDM.BO maintains a strong and stable balance sheet.
Profitability Score
WeakASTERDM.BO struggles to sustain strong margins.
Key Financial Metrics
Is ASTERDM.BO Expensive or Cheap?
P/E Ratio
ASTERDM.BO trades at 101.56 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ASTERDM.BO's PEG of -51.02 indicates potential undervaluation.
Price to Book
The market values Aster DM Healthcare Limited at 7.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 37.12 times EBITDA. This signals the market has high growth expectations.
How Well Does ASTERDM.BO Make Money?
Net Profit Margin
For every $100 in sales, Aster DM Healthcare Limited keeps $7.33 as profit after all expenses.
Operating Margin
Core operations generate 17.33 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $8.60 in profit for every $100 of shareholder equity.
ROA
Aster DM Healthcare Limited generates $4.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Aster DM Healthcare Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Aster DM Healthcare Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
ASTERDM.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
101.56
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-51.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.33
vs 25 benchmark
P/S Ratio
Price to sales ratio
7.45
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.46
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.10
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How ASTERDM.BO Stacks Against Its Sector Peers
| Metric | ASTERDM.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 101.56 | 29.45 | Worse (Expensive) |
| ROE | 8.60% | 779.00% | Weak |
| Net Margin | 7.33% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.46 | 0.26 | Weak (High Leverage) |
| Current Ratio | 2.10 | 4.65 | Strong Liquidity |
| ROA | 4.19% | -19344.00% (disorted) | Weak |
ASTERDM.BO outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Aster DM Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-97.25%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
11.82%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-98.00%
Industry Style: Defensive, Growth, Innovation
Declining